在经典霍奇金淋巴瘤中解开免疫微环境:预后和治疗影响

Vasileios Georgoulis1, Alexandra Papoudou-Bai2, Alexandros Makis3

  • 1Department of Hematology, School of Health Sciences, Faculty of Medicine, University of Ioannina, 45 500 Ioannina, Greece.

Biology
|June 28, 2023
PubMed
概括

经典霍奇金淋巴瘤 (cHL) 涉及在抑制性瘤微环境 (TME) 中的罕见癌细胞. 在TME内的巨细胞是新型免疫疗法的关键标,因为它们的可塑性和抗瘤的潜力.